Department of Medicine, Division of Nephrology, Hypertension and Endocrinology, Nihon University School of Medicine, 30-1 Oyaguchi-kami, Itabashi, Tokyo, Japan.
J Mol Med (Berl). 2014 May;92(5):509-21. doi: 10.1007/s00109-013-1118-x. Epub 2014 Jan 25.
Pyrrole-imidazole (PI) polyamides are nuclease-resistant novel compounds that inhibit transcription factors by binding to the minor groove of DNA. A PI polyamide that targets mouse ABCA1 and increases ABCA1 gene expression was designed and evaluated as an agent to increase plasma HDL concentration. A PI polyamide was designed to bind the activator protein-2 binding site of the mouse ABCA1 promoter. The effect of this PI polyamide on ABCA1 expression was evaluated by real-time RT-PCR and Western blotting using RAW264 cells. In vivo effects of this polyamide on ABCA1 gene expression and plasma HDL level were examined in C57B6 mice. One milligram per kilogram of body weight of PI polyamide was injected via the tail veins every 2 days for 1 week, and plasma lipid profiles were evaluated. PI polyamide showed a specific binding to the target DNA in gel mobility shift assay. Treatment of RAW264 cells with 1.0 μM PI polyamide significantly increased ABCA1 mRNA expression. PI polyamide also significantly increased apolipoprotein AI-mediated HDL biogenesis in RAW264 cells. Cellular cholesterol efflux mediated by apolipoprotein AI was significantly increased by the PI polyamide treatment. PI polyamide significantly increased expression of ABCA1 mRNA in the liver of C57B6 mice. Plasma HDL concentration was increased by PI polyamide administration. All of the HDL sub-fractions showed a tendency to increase after PI polyamide administration. The designed PI polyamide that targeted ABCA1 successfully increased ABCA1 expression and HDL biogenesis. This novel gene-regulating agent is promising as a useful compound to increase plasma HDL concentration.
A novel pyrrole-imidazole (PI) polyamide binds to ABCA1. PI polyamide interfered with binding of AP-2ɑ protein to the ABCA1 gene promoter. PI polyamide inhibited the AP-2ɑ-mediated reduction of ABCA1 gene and protein expression. PI polyamide increased ABCA1 protein and apolipoprotein AI mediated HDL biogenesis. PI polyamide is a new gene regulator for the prevention of atherosclerotic diseases.
吡咯-咪唑(PI)聚酰胺是一种新型的核酸酶抗性化合物,通过与 DNA 小沟结合来抑制转录因子。一种针对小鼠 ABCA1 并增加 ABCA1 基因表达的 PI 聚酰胺被设计并评估为增加血浆 HDL 浓度的药物。设计了一种 PI 聚酰胺来结合小鼠 ABCA1 启动子的激活蛋白-2 结合位点。通过实时 RT-PCR 和 Western blot 法使用 RAW264 细胞评估该 PI 聚酰胺对 ABCA1 表达的影响。在 C57B6 小鼠中检查了这种聚酰胺对 ABCA1 基因表达和血浆 HDL 水平的体内作用。每周通过尾静脉注射 1 毫克/千克体重的 PI 聚酰胺,每 2 天一次,共 1 周,并评估血浆脂质谱。凝胶迁移率变动测定法显示 PI 聚酰胺与靶 DNA 具有特异性结合。用 1.0 μM PI 聚酰胺处理 RAW264 细胞可显著增加 ABCA1 mRNA 表达。PI 聚酰胺还显著增加了 RAW264 细胞中载脂蛋白 AI 介导的 HDL 生成。载脂蛋白 AI 介导的细胞胆固醇流出被 PI 聚酰胺处理显著增加。PI 聚酰胺在 C57B6 小鼠的肝脏中显著增加 ABCA1 mRNA 的表达。PI 聚酰胺给药可增加血浆 HDL 浓度。PI 聚酰胺给药后所有 HDL 亚组分均有增加的趋势。设计靶向 ABCA1 的新型 PI 聚酰胺成功增加了 ABCA1 的表达和 HDL 的生成。这种新型基因调节剂有望成为增加血浆 HDL 浓度的有用化合物。
一种新型的吡咯-咪唑(PI)聚酰胺与 ABCA1 结合。PI 聚酰胺干扰 AP-2ɑ 蛋白与 ABCA1 基因启动子的结合。PI 聚酰胺抑制了 AP-2ɑ 介导的 ABCA1 基因和蛋白表达的减少。PI 聚酰胺增加了 ABCA1 蛋白和载脂蛋白 AI 介导的 HDL 生成。PI 聚酰胺是预防动脉粥样硬化疾病的新型基因调节剂。